Asia-Pacific Throat Cancer Diagnostics Market is expected to reach USD 431.98 million by 2030

Asia-Pacific throat cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.0% in the forecast period of 2023 to 2030 and is expected to reach USD 431.98 million by 2030 from USD 233.71 million in 2022.

Throat cancer is a type of cancer that forms in tissues of the pharynx (the hollow tube inside the neck that starts behind the nose and ends at the top of the windpipe and esophagus). Throat cancer includes cancer of the nasopharynx (the upper part of the throat behind the nose), the oropharynx (the middle part of the pharynx), and the hypopharynx (the bottom part of the pharynx). Cancer of the larynx (voice box) may also be included as a type of throat cancer. Most throat cancers are squamous cell carcinomas (cancer that begins in thin, flat cells that look like fish scales), also called pharyngeal cancer.

Access full report: https://www.databridgemarketresearch.com/reports/asia-pacific-throat-cancer-diagnostics-market

Drivers

Growing prevalence of throat cancer
Throat cancer is the second most common type of leukemia diagnosed in adults and children, but most cases occur in adults. Although it can be diagnosed at any age, it is uncommon before age 45. The average age of diagnosis is age 68. The rising use of cigarettes and other tobacco substitutes may be partially responsible for the rise in the prevalence of throat cancer.

People affected with throat cancer can see the symptoms such as a cough, changes in their voice, such as hoarseness or not speaking clearly, difficulty swallowing, ear pain, a lump or sore that doesn't heal, a sore throat, and weight loss among others.

Novel technological advancements in throat cancer diagnostics
Radiotherapy has an integral role in the treatment of throat cancer. Although radiotherapy has the potential to cure patients with advanced diseases, it also carries the potential for significant long-term morbidity. New technologies in the setting of head and neck radiotherapy are emerging, which have the potential to increase the cure rate and decrease toxicity. These new technologies include improved radiotherapy treatment design (intensity-modulated radiation therapy) and improved planning and implementation (image-guided radiation therapy).

Restraints

Late diagnosis and poor prognosis of throat cancer
Cancer is the leading cause of death worldwide. By 2030, it is anticipated that there will be 13.1 million more cancer-related deaths per year. However, if they are identified early on and given the right care, some cancers can be cured. The diagnostic process may experience delays in cancer diagnosis. When patients overlook or fail to respond to potentially cancerous signs, the late patient diagnosis will lead to the growth of cancerous tissue, worsening the cancer condition. The main cause of delayed presentation is a lack of public knowledge of early cancer signs, especially if such symptoms are unusual.

Thus, the late diagnosis often results from these factors, which result in poor prognosis. Thus, these are expected to restrain the growth of the Asia-Pacific throat cancer diagnostics market.

High cost for the installation of diagnostic devices

Cancer diagnostics have become increasingly expensive due to the growing number of throat cancer patients and the rising prices of medical devices. The modern technological devices used in cancer diagnosis also play a significant role in the high prices of cancer diagnostics, providing a definitive diagnosis for cancer in thyroid nodules with high accuracy. Therefore, the high cost of diagnostics procedures for throat cancers is hampering the market's growth.

The diagnostic products or devices which are used in the detection of cancer are becoming advanced. However, the procedure for cancer diagnostics is also costly, which hampers the growth of the throat cancer diagnostics market because the devices used in the process of cancer diagnosis are getting more expensive for the early detection of cancerous tissue, which results in to increase in the cost of diagnostics procedure.

Opportunities

Rise in healthcare expenditure for cancer diagnosis and treatment
Across the globe, research and development activities are escalating owing to the public health expenditure with economic performances. Rising healthcare expenditure could result in better provision of research and development opportunities. It is anticipated to increase the demand for throat diagnostics. Increasing the healthcare expenditure for cancer treatment also helps the patient take hassle-free advanced diagnostics and treatment for fast recovery. The spending on healthcare is made up of the combination of out-of-pocket payments (people paying for their care), government expenditure, and various sources such as different healthcare schemes published by the government in different regions. It also includes health insurance and activities by non-governmental organizations. This increasing healthcare expenditure for cancer treatment is an opportunity for the market's demand.

Government initiatives toward cancer diagnostics
The government plays a major role while taking the initiative for cancer diseases because cancer is a leading disease worldwide. Throat cancer has increased very rapidly in individuals in past decades. Throat cancer is the most prevalent cancer, with estimated 410,376 people new cases in 2022, according to cancer.gov.

There are several initiatives taken by the government that helps boost the market's demand, and these initiatives will increase awareness among people regarding their health and take early diagnosis for better cure and precaution. Growing healthcare expenditure is also beneficial for further economic growth and healthcare sector growth, and it is primarily fruitful as it significantly affects the development of better and advanced therapeutic options with various diagnostics products.

Challenges

Increased cost, safety, and convenience issues
Throat cancer is fatal, and the diagnosis process of this type of cancer also has safety issues. It is also not cost-effective. One of the most costly medical disorders to treat globally is cancer. Cancer patients may be hospitalized and receive a variety of therapies, such as surgery, radiation therapy, and systemic therapy. Health insurance premiums for cancer patients are now more expensive than in the past. In addition, their co-payment, deductible, and coinsurance costs are rising.

Rising helium shortage and rising risk of excessive radiation exposure are projected to restrict the use of CT scanners, threatening the possibilities of rising capital investments and low benefit-cost ratio for biomarkers. Many hospitals in developing countries cannot invest in diagnostic imaging equipment, which has led to increased use of reconstructed diagnostic imaging due to high expenditures and financial restrictions.

Recent Developments

In August 2022, F. Hoffmann-La Roche Ltd, announced the launch of the Digital LightCycler System, Roche's first digital polymerase chain reaction (PCR) system. This next-generation system detects disease and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods. This has helped the company to increase its Asia-Pacific presence in the market
In March 2021, Hologic, Inc. announced that the company had acquired Diagenode, a privately held Globalan developer and manufacturer of molecular diagnostic assays and epigenetics products. This further strengthens the molecular diagnostics business in the Asia-Pacific market

GET A PDF SAMPLE:
https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-throat-cancer-diagnostics-market

Asia-Pacific Throat Cancer Diagnostics Market Scope
The Asia-Pacific throat cancer diagnostics market is segmented into product type, test type, cancer type, stages, age group, end user, and distribution channel. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

Instruments
Consumables & accessories
On the basis of product type, the Asia-Pacific throat cancer diagnostics market is segmented into instruments and consumables & accessories.

Test Type

Imaging Test
Blood Test
Biopsy
Others
On the basis of test type, the Asia-Pacific throat cancer diagnostics market is segmented into imaging test, blood test, biopsy, and others.

Cancer Type

Pharyngeal cancer
Laryngeal cancer
On the basis of cancer type, the Asia-Pacific throat cancer diagnostics market is segmented into pharyngeal cancer and laryngeal cancer.

Stages

Stage 0
Stage I
Stage II
Stage III
Stage IV
On the basis of stages, the Asia-Pacific throat cancer diagnostics market is segmented into stage 0, stage I, stage II, stage III, and stage IV.

Age Group

30-65
65 and above
21-29
Below 21
On the basis of age group, the Asia-Pacific throat cancer diagnostics market is segmented into 30-65, 65 and above, 21-29, and below 21.

End User

Hospitals
Associated labs
Independent diagnostic laboratories
Diagnostic imaging centers
Cancer research institutes
Others
On the basis of end user, the Asia-Pacific throat cancer diagnostics market is segmented into hospitals, associated labs, independent diagnostic laboratories, diagnostic imaging centers, cancer research institutes, and others.

Distribution Channel

Direct tender
Retail sales
On the basis of distribution channel, the Asia-Pacific throat cancer diagnostics market is segmented into direct tender and retail sales.

Browse More reports:

https://dbmrbuisness.blogspot.com/2023/10/colorectal-cancer-diagnostics-market.html

https://dbmrbuisness.blogspot.com/2023/10/asia-pacific-colorectal-cancer.html

https://dbmrbuisness.blogspot.com/2023/10/europe-medical-device-testing-market.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.